What We're Reading: Page
Industry reads hand-picked by our editors
Aug 10, 2020
-
The New York Times
This Company Boasted to Trump About Its Covid-19 Vaccine. Experts Are Skeptical.
-
The Wall Street Journal
During Covid-19 Pandemic, Biotech IPOs Already Surpass Record
-
STAT
Pharma is showering Congress with cash, even amid coronavirus
-
Boston Business Journal
Biogen's Alzheimer's drug has a name. Here's what it is.
Aug 07, 2020
Aug 06, 2020
-
The Washington Post
FDA commissioner Stephen Hahn: Only a safe, effective vaccine will get our approval
-
The Wall Street Journal
Bausch Health to Spin Off Eye-Care Business
-
San Francisco Business Times
State AGs urge federal government to 'march in' on Gilead's Covid drug remdesivir
-
Endpoints News
Less than 3 months after launch, the AveXis crew's Taysha raises $95M Series B. Is an IPO next?
Aug 05, 2020
Aug 04, 2020
Aug 03, 2020
-
STAT
A tiny Texas company is running most U.S. drive-thru Covid-19 testing
-
Endpoints News
FDA hands MorphoSys and Incyte a quick OK on their potential blockbuster CAR-T alternative
-
MedTech Dive
Varian sold to Siemens Healthineers in $16.4B all-cash deal
-
Bloomberg
Johnson & Johnson Spravato Spray Approved for Treating Suicidal People
Jul 31, 2020
-
Reuters
China-backed hackers 'targeted COVID-19 vaccine firm Moderna'
-
The Wall Street Journal
Gilead Raises 2020 Profit Outlook on Remdesivir Demand
-
The Boston Globe
Brigham president resigns from Moderna board after conflict of interest questions raised
-
POLITICO
Vaccine distribution will be 'joint venture' between CDC and Pentagon
Previous
